Glaucoma Therapeutics Market Share, Industry Growth Analysis, Revenue, Size, Report 2022-2027

The global glaucoma therapeutics market size reached US$ 7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2027, exhibiting a growth rate (CAGR) of 6.52%

According to the latest report by IMARC Group, titled “Glaucoma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global glaucoma therapeutics market value reached US$ 7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2027, exhibiting a growth rate (CAGR) of 6.52% during 2022-2027

Glaucoma is an ocular disorder that damages the optic nerve of the patient. The structural changes in the optic nerves are usually caused by the abnormally high intraocular pressure (IOP) due to the extra build-up of fluid in the front part of the eyes. This condition can often lead to vision loss and permanent blindness in progressive cases. Numerous medications and therapies are prescribed to patients with glaucoma in order to avoid complete vision loss. Eye drops that belong to the class of beta-blockers, alpha agonists, prostaglandins and cholinergic are usually prescribed to reduce the production of fluid in the eyes. These drops can then be followed by conventional or laser surgeries for effective results. In several cases, a combination of both approaches is utilized for the treatment of glaucoma.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Glaucoma Therapeutics Market Trends:

The market is primarily driven by the increasing occurrence of glaucoma on the global level. This can be attributed to the rising number of patients who have diabetes due to their shifting lifestyle patterns and a lack of physical activities. This, along with the increasing geriatric population that is more susceptible to chronic ocular disorders, is providing a thrust to the market growth. Along with this, there has been a growing preference for the adoption of laser glaucoma surgeries among the patients as well as healthcare professionals on account of the successful outcomes of this procedure. Multiple professionals are also prescribing combination therapies for the treatment of glaucoma that involves the use of polymer-based contact lenses, drug-eluting punctal plugs, implantable extended-release devices, microneedle-injection devices and micro-dosing technologies. Coupled with the increasing number of awareness programs conducted by multiple organizations to spread awareness regarding the availability of effective glaucoma therapeutics, this is creating a positive outlook for the market. Some of the other factors contributing to the market growth include the continual research and development (R&D) activities to introduce innovative therapeutics and the improving healthcare infrastructure across the globe, especially in developing economies.

Request Free Sample Report: https://www.imarcgroup.com/glaucoma-therapeutics-market/requestsample

Global Glaucoma Therapeutics Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Aerie Pharmaceuticals Inc., Allergan Plc, Bausch & Lomb Incorporated (Bausch Health Companies Inc.), Inotek Pharmaceuticals Corp., Merck & Co. Inc., Novartis AG, Pfizer Inc., Santen Pharmaceutical Co. Ltd., SIFI S.p.A and Teva Pharmaceutical Industries Ltd.

The report has segmented the market on region, drug class, indication and end user.

Breakup by Drug Class:

• Prostaglandin Analogs

• Beta Blockers

• Alpha Adrenergic Agonists

• Carbonic Anhydrase Inhibitors

• Combination Drugs

• Others

Breakup by Indication:

• Open Angle Glaucoma

• Angle Closure Glaucoma

• Others

Breakup by End User:

• Hospitals

• Ophthalmic Clinics

• Ambulatory Surgery Centers

• Others

Breakup by Region:

• North America:( United States, Canada)

• Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America: (Brazil, Mexico,Others)

• Middle East and Africa

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2770&flag=C

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

Market Performance (2016-2021) Market Outlook (2022- 2027) Porter’s Five Forces Analysis Market Drivers and Success Factors SWOT Analysis Value Chain Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

Company Name: IMARC Group Email: [e-mail] Toll Free Number: USA: [phone] | Asia: [phone] Address: 30 N Gould St, Ste R Sheridan, WY 82801, USA Website: https://www.imarcgroup.com/ Linkedin: https://www.linkedin.com/company/imarc-group